Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination

Detalles Bibliográficos
Autores principales: Hettiarachchi, Ravin, Naidu, Kartik, Payne, Suzanne, Holland, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810227/
http://dx.doi.org/10.1016/j.pathol.2021.12.104
_version_ 1784644207178153984
author Hettiarachchi, Ravin
Naidu, Kartik
Payne, Suzanne
Holland, Juliette
author_facet Hettiarachchi, Ravin
Naidu, Kartik
Payne, Suzanne
Holland, Juliette
author_sort Hettiarachchi, Ravin
collection PubMed
description
format Online
Article
Text
id pubmed-8810227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88102272022-02-03 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination Hettiarachchi, Ravin Naidu, Kartik Payne, Suzanne Holland, Juliette Pathology Article Published by Elsevier B.V. 2022-03 2022-02-03 /pmc/articles/PMC8810227/ http://dx.doi.org/10.1016/j.pathol.2021.12.104 Text en Copyright © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hettiarachchi, Ravin
Naidu, Kartik
Payne, Suzanne
Holland, Juliette
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title_full Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title_fullStr Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title_full_unstemmed Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title_short Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
title_sort severe acute respiratory syndrome coronavirus 2 (sars-cov-2) antibody kinetics after bnt162b2 vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810227/
http://dx.doi.org/10.1016/j.pathol.2021.12.104
work_keys_str_mv AT hettiarachchiravin severeacuterespiratorysyndromecoronavirus2sarscov2antibodykineticsafterbnt162b2vaccination
AT naidukartik severeacuterespiratorysyndromecoronavirus2sarscov2antibodykineticsafterbnt162b2vaccination
AT paynesuzanne severeacuterespiratorysyndromecoronavirus2sarscov2antibodykineticsafterbnt162b2vaccination
AT hollandjuliette severeacuterespiratorysyndromecoronavirus2sarscov2antibodykineticsafterbnt162b2vaccination

Ejemplares similares